Science Explorer Interactive view Map
Research facility · Lexington · United States

Boston Collaborative Drug Surveillance Program

In research, Boston Collaborative Drug Surveillance Program stands highest in Medicine (#2,808 of 17,978 worldwide) and Health Sciences (#3,729 of 20,462 worldwide), over all time.

bcdsp.orgROR OpenAlex
World rank, all time
#13,344
of 42,892
Rank in United States
#2,930
of 8,685
Research works
207
▼ 33% vs 2013–17
Citations
15k
70.3 per fractional work
Top-10% rate
12.0%
record average 16.5%
Open access
32%
world 28%

What is Boston Collaborative Drug Surveillance Program known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #2,808 of 17,978 41.7%147
Health SciencesDomain #3,729 of 20,462 41.9%153

Each strip is that field’s whole ranked pool, with the notch where Boston Collaborative Drug Surveillance Program sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.44× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 1.14× its world share, 0 worksImmunology and Micro…Neuroscience: 0.33× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 22.55× its world share, 1 worksPharmacology, Toxico…Engineering: 0.01× its world share, 0 worksEngineeringMathematics: 0.21× its world share, 0 worksMathematicsHealth Professions: 1.36× its world share, 0 worksHealth ProfessionsMedicine: 3.64× its world share, 9 worksMedicineBusiness, Management and Accounting: 0.28× its world share, 0 worksBusiness, Management…Decision Sciences: 5.36× its world share, 1 worksDecision SciencesPsychology: 0.55× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 22.6×. Every wedge is a field page.

Who are the top researchers at Boston Collaborative Drug Surveillance Program?

Ranked on the composite score, Hershel Jick and Christoph Meier lead among researchers whose main affiliation is Boston Collaborative Drug Surveillance Program.

  1. 1 Hershel Jick United States · #12,528 worldwide 441 citations · 74 works
  2. 2 Christoph Meier United States · #314,899 worldwide 99 citations · 16 works
All ranked researchers at Boston Collaborative Drug Surveillance Program

Which keywords describe research at Boston Collaborative Drug Surveillance Program?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Epidemiology, Treatment, Clinical Trials, Breast Cancer, Diagnosis, Cardiovascular Risk and Cardiovascular Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation22▲ 4.5×32 topics
  2. Epidemiology22▲ 2.6×60 topics
  3. Treatment14▲ 5.3×25 topics
  4. Diagnosis11▲ 5.2×23 topics
  5. Oxidative Stress11▲ 2.9×20 topics
  6. Cardiovascular Disease11▲ 4.7×21 topics
  7. Risk Factors10▲ 4.5×15 topics
  8. Clinical Trials10▲ 7.5×9 topics
  9. Breast Cancer9▲ 16×8 topics
  10. Metabolic Syndrome9▲ 5.2×16 topics
  11. Cancer9▲ 3.1×11 topics
  12. Cardiovascular Risk9▲ 12×7 topics
  13. Adverse Drug Reactions8▲ 62×3 topics
  14. Genetics7▲ 4.6×13 topics
  15. Depression7▲ 4.6×8 topics
  16. Pregnancy7▲ 15×4 topics
  17. Clinical Practice Guidelines7▲ 5.9×9 topics
  18. Elderly6▲ 11×4 topics
  19. Biomarkers6▲ 4.5×7 topics
  20. Estrogen6▲ 36×2 topics
  21. Medication Adherence6▲ 47×2 topics
  22. Statins6▲ 34×2 topics
  23. Antithrombotic Therapy5▲ 25×2 topics
  24. Pathogenesis5▲ 4.7×12 topics
  25. Rheumatoid Arthritis5▲ 25×2 topics
  26. Cognitive Function5▲ 12×7 topics
  27. Inappropriate Medication Use5▲ 62×1 topic
  28. Polypharmacy5▲ 62×1 topic
  29. Autoantibodies5▲ 9.7×5 topics
  30. Bone Mineral Density5▲ 26×3 topics
  31. Hormone Therapy5▲ 21×3 topics
  32. Genetic Variants4▲ 10×6 topics
  33. Reproductive Health4▲ 51×3 topics
  34. Nuclear Receptors4▲ 12×5 topics
  35. Off-Label Drug Use4▲ 58×1 topic
  36. Pediatric Pharmacokinetics4▲ 58×1 topic
  37. Teratogenicity4▲ 32×2 topics
  38. Family Planning4▲ 39×2 topics
  39. Cardiovascular Disease Prevention4▲ 25×2 topics
  40. Colorectal Cancer4▲ 20×2 topics

Which research topics does Boston Collaborative Drug Surveillance Program publish most on?

By volume in 2022–2025: Global Cancer Incidence and Screening, Venous Thromboembolism Diagnosis and Management, Medication Adherence and Compliance and Pharmacovigilance and Adverse Drug Reactions.

Global Cancer Incidence …0Global Cancer Incidence and Screening: 0 fractional worksVenous Thromboembolism D…0Venous Thromboembolism Diagnosis and Management: 0 fractional worksMedication Adherence and Compliance: 0 fractional worksPharmacovigilance and Adverse Drug Reactions: 0 fractional worksPancreatic and Hepatic Oncology Research: 0 fractional worksColorectal Cancer Screening and Detection: 0 fractional worksLipoproteins and Cardiovascular Health: 0 fractional worksAntiplatelet Therapy and…0Antiplatelet Therapy and Cardiovascular Diseases: 0 fractional worksPharmacogenetics and Drug Metabolism: 0 fractional worksData Quality and Management: 0 fractional works
OncologyInternal MedicineFamily PracticeToxicology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Global Cancer Incidence and Screening Oncology 0 works
  2. 2 Venous Thromboembolism Diagnosis and Management Internal Medicine 0 works
  3. 3 Medication Adherence and Compliance Family Practice 0 works
  4. 4 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 0 works
  6. 6 Colorectal Cancer Screening and Detection Oncology 0 works
  7. 7 Lipoproteins and Cardiovascular Health Surgery 0 works
  8. 8 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 0 works
  9. 9 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  10. 10 Data Quality and Management Management Science and Operations Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.2%not open67.8%

World: 28% of research is openly available.

with international co-authors31.3%domestic only68.7%

World: 19% is written across borders.

How has Boston Collaborative Drug Surveillance Program's research output changed?

Output in 2018–2022 was 33% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Lexington

All research institutions in Lexington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.